Repeat Administration of Bone Marrow-Derived Mesenchymal Stem Cells for Treatment of Amyotrophic Lateral Sclerosis-Reference-Cited by-同舟云学术

Repeat Administration of Bone Marrow-Derived Mesenchymal Stem Cells for Treatment of Amyotrophic Lateral Sclerosis

Published:2020-12-10 Issue: Volume:26 Page:
ISSN:1643-3750
Container-title:Medical Science Monitor
language:en
Short-container-title:Med Sci Monit

Author:

Siwek Tomasz¹,Jezierska-Woźniak Katarzyna²,Maksymowicz Stanisław³,Barczewska Monika⁴,Sowa Mariusz⁴,Badowska Wanda⁵,Maksymowicz Wojciech⁴

Affiliation:

1. Department of Neurology, School of Medicine, University of Warmia and Mazury, Olsztyn, Poland

2. Laboratory for Regenerative Medicine, School of Medicine, University of Warmia and Mazury, Olsztyn, Poland

3. Department of Psychology and Sociology of Health and Public Health, School of Public Health, Collegium Medicum, University of Warmia and Mazury, Olsztyn, Poland

4. Department of Neurosurgery, School of Medicine, University of Warmia and Mazury, Olsztyn, Poland

5. Department of Clinical Paediatrics, School of Medicine, University of Warmia and Mazury, Olsztyn, Poland

Publisher

International Scientific Information, Inc.

Subject

General Medicine

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current potential therapeutics of amyotrophic lateral sclerosis;Frontiers in Neurology;2024-04-24

2. Mesenchymal stem cell-based therapies for treating well-studied neurological disorders: a systematic review;Frontiers in Medicine;2024-03-27

3. Proteomic analysis of cerebrospinal fluid of amyotrophic lateral sclerosis patients in the presence of autologous bone marrow derived mesenchymal stem cells;2023-12-07

4. Repeat intramuscular transplantation of human dental pulp stromal cells is more effective in sustaining Schwann cell survival and myelination for functional recovery after onset of diabetic neuropathy;Cytotherapy;2023-11

5. Unproven cell interventions in Poland and the exploitation of European Union law on advanced therapy medicinal products;Stem Cell Reports;2023-08